Opportunity Information: Apply for RFA MH 21 151
The National Institutes of Health (NIH) funding opportunity titled "Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional)" (Funding Opportunity Number RFA-MH-21-151) supports research aimed at improving HIV prevention for women living in the Southern United States. Using the R01 grant mechanism, the program is designed to stimulate research that goes beyond single-level solutions and instead uses multi-level approaches that reflect the real-world mix of individual, interpersonal, community, clinical, and structural factors influencing HIV prevention. The "clinical trial optional" designation means applicants may propose studies that include a clinical trial, but a trial is not required if the research aims can be met through other rigorous designs.
The central purpose of the initiative is twofold. First, it seeks to clarify what is getting in the way of women in the Southern U.S. using available HIV prevention strategies, as well as what helps them access and use those strategies consistently. This includes identifying barriers and facilitators related to awareness, stigma, risk perception, healthcare access, provider practices, social and relationship dynamics, economic constraints, transportation, insurance coverage, housing instability, local policies, and broader inequities that shape health outcomes in the region. Second, it prioritizes the development and testing of new or improved interventions that can increase both uptake and adherence to HIV prevention options among Southern U.S.-based women. In practice, this points toward research that not only introduces prevention tools but also addresses the conditions that determine whether women can start them, stay on them, and benefit from them over time.
Because the opportunity emphasizes "multiple levels of influence," competitive applications would generally be expected to consider intervention strategies that do more than educate individuals. Examples of multi-level work could include combining patient-facing support (such as counseling, navigation, reminders, or peer support) with clinic-level changes (like provider training, streamlined prescribing workflows, or integration into routine care), and community or structural components (such as partnerships with trusted community organizations, stigma-reduction strategies, or approaches to reduce logistical barriers like transportation and childcare). The focus is specifically on women in the Southern U.S., a region that has faced persistent HIV disparities and where social determinants and healthcare access gaps can strongly affect prevention outcomes.
Eligibility is broad and includes many types of U.S.-based organizations and government entities. Eligible applicants listed include state, county, city or township governments, special district governments, independent school districts, and public housing authorities/Indian housing authorities. Higher education institutions are eligible, including public and state-controlled institutions of higher education and private institutions of higher education. Tribal entities are eligible as well, including federally recognized Native American tribal governments and Native American tribal organizations other than federally recognized tribal governments. The opportunity is also open to nonprofit organizations both with and without 501(c)(3) status (excluding those that are institutions of higher education under the nonprofit category), for-profit organizations other than small businesses, and small businesses. The announcement also explicitly highlights additional eligible applicant types such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions.
At the same time, the funding notice clearly restricts foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are also not eligible, and foreign components, as defined by the NIH Grants Policy Statement, are not allowed. In other words, projects must be fully domestic in terms of applicant organization and supported components.
In the source data provided, the opportunity is categorized as discretionary funding, with the funding instrument listed as a grant and activity categories in education and health. The CFDA numbers associated with the opportunity are 93.242, 93.279, 93.307, and 93.313. The opportunity was created on 2020-11-17, with an original closing date of 2021-01-11. An award ceiling and expected number of awards are not specified in the provided fields, which often means applicants need to refer to the full NIH announcement for budget guidance and anticipated award volume.
Overall, this grant opportunity is aimed at strengthening HIV prevention among women in the Southern U.S. by supporting research that (1) produces a clearer, evidence-based understanding of why prevention tools are underused or difficult to sustain in this region and (2) designs and rigorously evaluates interventions that can realistically increase initiation and ongoing use of HIV prevention strategies in the contexts where women live and receive care.Apply for RFA MH 21 151
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Strengthening HIV Prevention Efforts for Women in the Southern U.S. (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279, 93.307, 93.313.
- This funding opportunity was created on 2020-11-17.
- Applicants must submit their applications by 2021-01-11. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education, Health
Next opportunity: NEI Institutional Mentored Physician Scientist Award (K12 Clinical Trial Optional)
Previous opportunity: Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA MH 21 151
Applicants also applied for:
Applicants who have applied for this opportunity (RFA MH 21 151) also looked into and applied for these:
| Funding Opportunity |
|---|
| Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Apply for PAR 21 065 Funding Number: PAR 21 065 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) Apply for PAR 21 066 Funding Number: PAR 21 066 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Apply for PAR 21 067 Funding Number: PAR 21 067 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 003 Funding Number: RFA CA 21 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed) Apply for RFA CA 21 005 Funding Number: RFA CA 21 005 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 004 Funding Number: RFA CA 21 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) Apply for RFA CA 21 006 Funding Number: RFA CA 21 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) Apply for RFA CA 21 009 Funding Number: RFA CA 21 009 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Apply for RFA CA 21 008 Funding Number: RFA CA 21 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Apply for RFA CA 21 012 Funding Number: RFA CA 21 012 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Apply for RFA CA 21 007 Funding Number: RFA CA 21 007 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Apply for RFA CA 21 011 Funding Number: RFA CA 21 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Apply for RFA CA 21 010 Funding Number: RFA CA 21 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed) Apply for RFA CA 21 001 Funding Number: RFA CA 21 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Apply for RFA CA 21 014 Funding Number: RFA CA 21 014 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Cellular Cancer Biology Imaging Research (CCBIR) Program (U54, Clinical Trial Not Allowed) Apply for RFA CA 21 002 Funding Number: RFA CA 21 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,250,000 |
| Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 21 031 Funding Number: RFA DA 21 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Digital Technologies to Address the Social Determinants of Health in Context of Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 21 032 Funding Number: RFA DA 21 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Music and Health: Understanding And Developing Music Medicine (R21 Clinical Trial Optional) Apply for PAR 21 099 Funding Number: PAR 21 099 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Novel Approaches to Decrease Stigma of Substance Use Disorders in order to Facilitate Prevention, Treatment, and Support During Recovery (R41/R42 - Clinical Trials Optional) Apply for RFA DA 21 015 Funding Number: RFA DA 21 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $256,580 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA MH 21 151", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
